| Novel drug delivery systems targeting oxidative stress in chronic obstructive pulmonary disease: a review Y Xu, H Liu, L Song Journal of nanobiotechnology 18, 1-25, 2020 | 69 | 2020 |
| Leucine improves the aerosol performance of dry powder inhaler formulations of siRNA-loaded nanoparticles Y Xu, L Harinck, AG Lokras, P Gerde, E Selg, CO Sjöberg, H Franzyk, ... International Journal of Pharmaceutics 621, 121758, 2022 | 33 | 2022 |
| Mechanisms of deformable nanovesicles based on insulin-phospholipid complex for enhancing buccal delivery of insulin Y Xu, X Zhang, Y Zhang, J Ye, HL Wang, X Xia, Y Liu International journal of nanomedicine, 7319-7331, 2018 | 29 | 2018 |
| Inhaled RNA therapeutics for obstructive airway diseases: recent advances and future prospects Y Xu, A Thakur, Y Zhang, C Foged Pharmaceutics 13 (2), 177, 2021 | 25 | 2021 |
| Cell-penetrating peptide enhanced insulin buccal absorption Y Xu, X Zhang, N Wang, X Pei, Y Guo, J Wang, S Barth, F Yu, SJ Lee, ... International Journal of Pharmaceutics 584, 119469, 2020 | 21 | 2020 |
| Epidemiological and clinical characteristics of 2019 novel coronavirus disease (COVID-19) in Jilin, China: a descriptive study H Liu, J Gao, Y Wang, J Jie, J Luo, Y Xu, H Sun, L Song, D Li, L Peng, ... Medicine 99 (47), e23407, 2020 | 14 | 2020 |
| Insights into the mechanisms of interaction between inhalable lipid-polymer hybrid nanoparticles and pulmonary surfactant Y Xu, E Parra-Ortiz, F Wan, O Cañadas, B Garcia-Alvarez, A Thakur, ... Journal of Colloid and Interface Science 633, 511-525, 2023 | 11 | 2023 |
| Factors affecting the buccal delivery of deformable nanovesicles based on insulin–phospholipid complex: an in vivo investigation Y Yang, Y Guo, Y Xu, Y Meng, X Zhang, X Xia, YL Liu Drug Delivery 27 (1), 900-908, 2020 | 8 | 2020 |
| Optimizing the design and dosing of dry powder inhaler formulations of the cationic liposome adjuvant CAF® 01 for pulmonary immunization A Thakur, Y Xu, GC Garcia, S Feng, F Rose, P Gerde, P Andersen, ... Frontiers in Drug Delivery, 27, 2022 | 6 | 2022 |
| Improved safety and anti-glioblastoma efficacy of cat3-encapsulated smedds through metabolism modification H Wang, L Li, J Ye, W Dong, X Zhang, Y Xu, J Hu, R Wang, X Xia, Y Yang, ... Molecules 26 (2), 484, 2021 | 6 | 2021 |
| Stabilization of deformable nanovesicles based on insulin-phospholipid complex by freeze-drying Y Xu, Y Guo, Y Yang, Y Meng, X Xia, Y Liu Pharmaceutics 11 (10), 539, 2019 | 6 | 2019 |
| Deformable nanovesicle-loaded gel for buccal insulin delivery Y Guo, Y Yang, Y Xu, Y Meng, J Ye, X Xia, Y Liu Pharmaceutics 14 (11), 2262, 2022 | 4 | 2022 |
| Inhalable composite microparticles containing siRNA-loaded lipid-polymer hybrid nanoparticles: Saccharides and leucine preserve aerosol performance and long-term physical stability Y Xu, ET Turan, Z Shi, H Franzyk, A Thakur, C Foged Frontiers in Drug Delivery 2, 945459, 2022 | 4 | 2022 |
| Effect of lipid-polymer hybrid nanoparticles on the biophysical function and lateral structure of pulmonary surfactant: Mechanistic in vitro studies Y Xu, O Cañadas, A Alonso, H Franzyk, A Thakur, J Pérez-Gil, C Foged Journal of Colloid and Interface Science 654, 1111-1123, 2024 | | 2024 |
| Manipulating cell motility by: Speeding up or slowing down? Y Xu, T Jin Journal of Translational Internal Medicine, 2023 | | 2023 |
Camilla FogedProfessor of Vaccine Design and Delivery, University of CopenhagenVerified email at sund.ku.dk
